SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robyn G. Langham, Darren J. Kelly, Urotensin II and the kidney, Current Opinion in Nephrology and Hypertension, 2013, 22, 1, 107

    CrossRef

  2. 2
    Yung-Ho Hsu, Tso-Hsiao Chen, Yen-Cheng Chen, Chung-Yi Cheng, Yuh-Mou Sue, Jia-Rung Chen, Cheng-Hsien Chen, Urotensin II exerts antiapoptotic effect on NRK-52E cells through prostacyclin-mediated peroxisome proliferator-activated receptor alpha and Akt activation, Molecular and Cellular Endocrinology, 2013, 381, 1-2, 168

    CrossRef

  3. 3
    A. Mosenkis, R. R. Kallem, T. M. Danoff, N. Aiyar, J. Bazeley, R. R. Townsend, Renal impairment, hypertension and plasma urotensin II, Nephrology Dialysis Transplantation, 2011, 26, 2, 609

    CrossRef

  4. 4
    Roberta D'Emmanuele Di Villa Bianca, Giuseppe Cirino, Emma Mitidieri, Ciro Coletta, Gianluca Grassia, Fiorentina Roviezzo, Paolo Grieco, Ettore Novellino, Ciro Imbimbo, Vincenzo Mirone, Raffaella Sorrentino, Urotensin II: A Novel Target in Human Corpus Cavernosum, The Journal of Sexual Medicine, 2010, 7, 5
  5. 5
    Joseph Cheriyan, Timothy J. Burton, Timothy J. Bradley, Sharon M. L. Wallace, Kaisa M. Mäki-Petäjä, Isla S. Mackenzie, Carmel M. McEniery, John Brown, Ian B. Wilkinson, The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans, British Journal of Clinical Pharmacology, 2009, 68, 4
  6. 6
    A. D. Leonard, J. P. Thompson, E. L. Hutchinson, S. P. Young, J. McDonald, J. Swanevelder, D. G. Lambert, Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease, British Journal of Anaesthesia, 2009, 102, 4, 477

    CrossRef

  7. 7
    Markus Tölle, Markus van der Giet, Cardiorenovascular effects of urotensin II and the relevance of the UT receptor, Peptides, 2008, 29, 5, 743

    CrossRef

  8. 8
    Julien Chuquet, Clotilde Lecrux, David Chatenet, Jérôme Leprince, Laurent Chazalviel, Simon Roussel, Eric T. MacKenzie, Hubert Vaudry, Omar Touzani, Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats, Experimental Neurology, 2008, 210, 2, 577

    CrossRef

  9. 9
    Rajbabu Pakala, Role of urotensin II in atherosclerotic cardiovascular diseases, Cardiovascular Revascularization Medicine, 2008, 9, 3, 166

    CrossRef

  10. 10
    Eugen Brailoiu, Xiaohua Jiang, G. Cristina Brailoiu, Jun Yang, Jaw Kang Chang, Hong Wang, Nae J. Dun, State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells, Peptides, 2008, 29, 5, 721

    CrossRef

  11. 11
    Alan G. Japp, David E. Newby, The apelin–APJ system in heart failure, Biochemical Pharmacology, 2008, 75, 10, 1882

    CrossRef

  12. 12
    Kwok Leung Ong, Louisa Y.F. Wong, Bernard M.Y. Cheung, The role of urotensin II in the metabolic syndrome, Peptides, 2008, 29, 5, 859

    CrossRef

  13. 13
    Nirav Desai, Jameel Sajjad, William H. Frishman, Urotensin II, Cardiology in Review, 2008, 16, 3, 142

    CrossRef

  14. 14
    P Ravani, G Tripepi, P Pecchini, F Mallamaci, F Malberti, C Zoccali, Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease, Kidney International, 2008, 73, 1, 95

    CrossRef

  15. 15
    John McDonald, Madura Batuwangala, David G. Lambert, Role of urotensin II and its receptor in health and disease, Journal of Anesthesia, 2007, 21, 3, 378

    CrossRef

  16. 16
    Henry Krum, Will Kemp, Therapeutic potential of blockade of the Urotensin II system in systemic hypertension, Current Hypertension Reports, 2007, 9, 1, 53

    CrossRef

  17. 17
    William Kemp, Henry Krum, John Colman, Michael Bailey, Tim Yandle, Mark Richards, Stuart Roberts, Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension, Liver International, 2007, 27, 9
  18. 18
    Kwok Leung Ong, Louisa Y.F. Wong, Yu Bun Man, Raymond Y.H. Leung, You-Qiang Song, Karen S.L. Lam, Bernard M.Y. Cheung, Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance, Peptides, 2006, 27, 7, 1659

    CrossRef

  19. 19
    Valeria Camarda, Martina Spagnol, Wei Song, Raffaella Vergura, Adelheid L Roth, Jonathan P Thompson, David J Rowbotham, Remo Guerrini, Erika Marzola, Severo Salvadori, Paolo Cavanni, Domenico Regoli, Stephen A Douglas, David G Lambert, Girolamo Calò, In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP-803), British Journal of Pharmacology, 2006, 147, 1
  20. 20
    Sheila M Gardiner, Julie E March, Philip A Kemp, Janet J Maguire, Rhoda E Kuc, Anthony P Davenport, Terence Bennett, Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation, British Journal of Pharmacology, 2006, 147, 6
  21. 21
    S.G. Hood, A.M.D. Watson, C.N. May, Cardiac actions of central but not peripheral urotensin II are prevented by β-adrenoceptor blockade, Peptides, 2005, 26, 7, 1248

    CrossRef

  22. 22
    Nambi Aiyar, Douglas G. Johns, Zhaohui Ao, Jyoti Disa, David J. Behm, James J. Foley, Peter T. Buckley, Henry M. Sarau, Harjeet K van-der-Keyl, Nabil A. Elshourbagy, Stephen A. Douglas, Cloning and pharmacological characterization of the cat urotensin-II receptor (UT), Biochemical Pharmacology, 2005, 69, 7, 1069

    CrossRef

  23. 23
    Ozcan Balat, Fuat Aksoy, Irfan Kutlar, Mete Gurol Ugur, Hakan Iyikosker, Ayse Balat, Rüksen Anarat, Increased plasma levels of Urotensin-II in preeclampsia–eclampsia: a new mediator in pathogenesis?, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005, 120, 1, 33

    CrossRef

  24. 24
    Stephen A Douglas, David J Behm, Nambi V Aiyar, Diane Naselsky, Jyoti Disa, David P Brooks, Eliot H Ohlstein, John G Gleason, Henry M Sarau, James J Foley, Peter T Buckley, Dulcie B Schmidt, William E Wixted, Katherine Widdowson, Graham Riley, Jian Jin, Timothy F Gallagher, Stanley J Schmidt, Lance Ridgers, Lisa T Christmann, Richard M Keenan, Steven D Knight, Dashyant Dhanak, Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375, British Journal of Pharmacology, 2005, 145, 5
  25. 25
    Kwok-Leung Ong, Bernard M.Y. Cheung, Karen Siu-Ling Lam, Urotensin II and the Circulatory System, Hong Kong Journal of Nephrology, 2005, 7, 1, 9

    CrossRef

  26. 26
    R.J BALMENT, W SONG, N ASHTON, Urotensin II: Ancient Hormone with New Functions in Vertebrate Body Fluid Regulation, Annals of the New York Academy of Sciences, 2005, 1040, 1
  27. 27
    Kwok Leung Ong, Karen S. L. Lam, Bernard M. Y. Cheung, Urotensin II: Its Function in Health and Its Role in Disease, Cardiovascular Drugs and Therapy, 2005, 19, 1, 65

    CrossRef

  28. 28
    Sheila M Gardiner, Julie E March, Philip A Kemp, Terence Bennett, Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response, British Journal of Pharmacology, 2004, 143, 3
  29. 29
    Janet J. Maguire, Rhoda E. Kuc, Katherine E. Wiley, Matthias J. Kleinz, Anthony P. Davenport, Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries, Peptides, 2004, 25, 10, 1767

    CrossRef

  30. 30
    Harald Lapp, Guido Boerrigter, Lisa C. Costello-Boerrigter, Karsten Jaekel, Thomas Scheffold, Ingo Krakau, Matthias Schramm, Hartmut Guelker, Johannes-Peter Stasch, Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy, International Journal of Cardiology, 2004, 94, 1, 93

    CrossRef

  31. 31
    Stephen A. Douglas, Dashyant Dhanak, Douglas G. Johns, From ‘gills to pills’: urotensin-II as a regulator of mammalian cardiorenal function, Trends in Pharmacological Sciences, 2004, 25, 2, 76

    CrossRef

  32. 32
    W Stephen Waring, David J Webb, Is there a need for novel antihypertensive therapies?, Drug Discovery Today: Therapeutic Strategies, 2004, 1, 2, 143

    CrossRef

  33. 33
    A. Mark Richards, Chris Charles, Urotensin II in the cardiovascular system, Peptides, 2004, 25, 10, 1795

    CrossRef

  34. 34
    Anna M.D. Watson, Clive N. May, Urotensin II, a novel peptide in central and peripheral cardiovascular control, Peptides, 2004, 25, 10, 1759

    CrossRef

  35. 35
    Döne Onan, Ross D. Hannan, Walter G. Thomas, Urotensin II: the old kid in town, Trends in Endocrinology & Metabolism, 2004, 15, 4, 175

    CrossRef

  36. 36
    Sheila A Doggrell, Urotensin-II and the cardiovascular system – the importance of developing modulators, Expert Opinion on Investigational Drugs, 2004, 13, 5, 479

    CrossRef

  37. 37
    Tsukasa Sugo, Yuko Murakami, Yukio Shimomura, Mioko Harada, Michiko Abe, Yoshihiro Ishibashi, Chieko Kitada, Nobuyuki Miyajima, Nobuhiro Suzuki, Masaaki Mori, Masahiko Fujino, Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain, Biochemical and Biophysical Research Communications, 2003, 310, 3, 860

    CrossRef

  38. 38
    P D'Orléans-Juste, M Plante, J C Honoré, E Carrier, J Labonté, Synthesis and degradation of endothelin-1, Canadian Journal of Physiology and Pharmacology, 2003, 81, 6, 503

    CrossRef